Zydus Lifesciences informs about press release

15 Dec 2023 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated December 15, 2023 titled ‘Zydus receives final approval from the USFDA for Darunavir Tablets 600 mg and 800 mg, and tentative approval for 75 mg and 150 mg tablets.’

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

910.00 5.15 (0.57%)
16-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1699.75
Dr. Reddys Lab 1269.30
Cipla 1355.80
Zydus Lifesciences 910.00
Lupin 2220.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×